ACUTA CAPITAL PARTNERS, LLC
CIK
1582844
Location
REDWOOD CITY, CA
Portfolio Value
Small
$138,348,384
Diversification
Diversified
Filing Date
Global Rank
#4,672
/ 8,232
▲ 447
Top Industry
Biotechnology
97.5%
3Y Alpha vs SPY
+1.8%
Period ended 2 months ago
Filed May 15, 2026 · 30d
25 quarters · since Mar 2020
Clone Performance
Jun 2023–Jun 2026 · vs SPYHypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.
Cloned portfolio
+84.4%
SPY
+76.3%
Annualised alpha
+1.8%
Max drawdown
−45.3%
Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.
Portfolio Concentration
25 positions · as of Mar 31, 2026 · Δ vs Dec 31, 2025Top Position
19.8%
−0.4 pts
Top 5
59.8%
−1.3 pts
Top 10
79.3%
−0.1 pts
HHI
1,016
Diversified−31
Portfolio Trend
25 quarters · across all stocks
Sector Breakdown
As of Mar 31, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 100.0% | $138,348,384 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased
6 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| STRO | Sutro Biopharma, Inc. | +201,974 | 269,425 | $6,711,376 | |
| TNGX | Tango Therapeutics, Inc. | +159,099 | 441,831 | $9,243,104 | |
| MLTX | MoonLake Immunotherapeutics | +132,480 | 191,760 | $3,574,406 | |
| DRUG | Bright Minds Biosciences Inc. | +27,519 | 111,996 | $8,172,348 | |
| RVMD | Revolution Medicines, Inc. | +17,658 | 26,069 | $2,535,210 | |
| PRAX | Praxis Precision Medicines, Inc. | +1,865 | 84,901 | $27,354,253 | |
| No positions match the current search. | |||||
Trimmed
Positions the filer reduced
13 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| OCUL | Ocular Therapeutix, Inc | −460,887 | 592,108 | $5,015,154 | |
| CMPX | Compass Therapeutics, Inc. | −244,224 | 849,076 | $4,491,612 | |
| AMLX | Amylyx Pharmaceuticals, Inc. | −182,191 | 151,067 | $2,099,831 | |
| TERN | Terns Pharmaceuticals, Inc. | −141,323 | 495,772 | $26,137,099 | |
| TSHA | Taysha Gene Therapies, Inc. | −15,363 | 439,464 | $1,964,404 | |
| SRZN | Surrozen, Inc./DE | −5,568 | 172,847 | $5,035,033 | |
| DSGN | Design Therapeutics, Inc. | −5,006 | 145,900 | $1,552,376 | |
| OCS | Oculis Holding AG | −3,438 | 98,339 | $2,614,834 | |
| UNCY | Unicycive Therapeutics, Inc. | −2,026 | 57,959 | $381,370 | |
| LBRX | Lb Pharmaceuticals Inc | −1,081 | 28,919 | $713,142 | |
| MAZE | Maze Therapeutics, Inc. | −665 | 19,335 | $577,149 | |
| ARGX | Argenx SE | −161 | 4,690 | $3,424,872 | |
| UTHR | UNITED THERAPEUTICS Corp | −72 | 2,224 | $1,318,787 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarter
4 positions
Sold Out
Positions the filer fully exited
7 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| JAZZ | Jazz Pharmaceuticals plc | 29,008 | $4,931,360 | |
| INSM | INSMED Inc | 25,878 | $4,503,807 | |
| ZYME | Zymeworks Inc. | 80,143 | $2,110,165 | |
| INBX | Inhibrx Biosciences, Inc. | 16,377 | $1,293,783 | |
| VSTM | Verastem, Inc. | 143,446 | $1,107,403 | |
| DNTH | Dianthus Therapeutics, Inc. /DE/ | 16,708 | $688,536 | |
| KTTA | Pasithea Therapeutics Corp. | 450,000 | $580,500 | |
| No positions match the current search. | ||||
25 positions ·
$138,348,384 total
· as of Mar 31, 2026
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| PRAX |
Praxis Precision Medicines, Inc.
Healthcare
|
Added | 84,901 | $27,354,253 | 19.77% | |
| TERN |
Terns Pharmaceuticals, Inc.
Healthcare
|
Reduced | 495,772 | $26,137,099 | 18.89% | |
| WHWK |
Whitehawk Therapeutics, Inc.
Healthcare
|
Held | 3,410,402 | $11,765,886 | 8.50% | |
| TNGX |
Tango Therapeutics, Inc.
Healthcare
|
Added | 441,831 | $9,243,104 | 6.68% | |
| DRUG |
Bright Minds Biosciences Inc.
Healthcare
|
Added | 111,996 | $8,172,348 | 5.91% | |
| STRO |
Sutro Biopharma, Inc.
Healthcare
|
Added | 269,425 | $6,711,376 | 4.85% | |
| ERAS |
Erasca, Inc.
Healthcare
|
NEW | 354,575 | $5,737,023 | 4.15% | |
| SRZN |
Surrozen, Inc./DE
Healthcare
|
Reduced | 172,847 | $5,035,033 | 3.64% | |
| OCUL |
Ocular Therapeutix, Inc
Healthcare
|
Reduced | 592,108 | $5,015,154 | 3.63% | |
| CMPX |
Compass Therapeutics, Inc.
Healthcare
|
Reduced | 849,076 | $4,491,612 | 3.25% | |
| NERV |
Minerva Neurosciences, Inc.
Healthcare
|
Held | 709,500 | $4,274,737 | 3.09% | |
| MLTX |
MoonLake Immunotherapeutics
Healthcare
|
Added | 191,760 | $3,574,406 | 2.58% | |
| ARGX |
Argenx SE
Healthcare
|
Reduced | 4,690 | $3,424,872 | 2.48% | |
| OCS |
Oculis Holding AG
Healthcare
|
Reduced | 98,339 | $2,614,834 | 1.89% | |
| RVMD |
Revolution Medicines, Inc.
Healthcare
|
Added | 26,069 | $2,535,210 | 1.83% | |
| AMLX |
Amylyx Pharmaceuticals, Inc.
Healthcare
|
Reduced | 151,067 | $2,099,831 | 1.52% | |
| TSHA |
Taysha Gene Therapies, Inc.
Healthcare
|
Reduced | 439,464 | $1,964,404 | 1.42% | |
| IDYA |
IDEAYA Biosciences, Inc.
Healthcare
|
NEW | 48,584 | $1,618,818 | 1.17% | |
| DSGN |
Design Therapeutics, Inc.
Healthcare
|
Reduced | 145,900 | $1,552,376 | 1.12% | |
| UTHR |
UNITED THERAPEUTICS Corp
Healthcare
|
Reduced | 2,224 | $1,318,787 | 0.95% | |
| TRDA |
Entrada Therapeutics, Inc.
Healthcare
|
NEW | 89,358 | $1,127,697 | 0.82% | |
| AVTX |
Avalo Therapeutics, Inc.
Healthcare
|
NEW | 60,808 | $907,863 | 0.66% | |
| LBRX |
Lb Pharmaceuticals Inc
Healthcare
|
Reduced | 28,919 | $713,142 | 0.52% | |
| MAZE |
Maze Therapeutics, Inc.
Healthcare
|
Reduced | 19,335 | $577,149 | 0.42% | |
| UNCY |
Unicycive Therapeutics, Inc.
Healthcare
|
Reduced | 57,959 | $381,370 | 0.28% |